A kind of small molecule oxathiazide derivative and its application

A technology of oxathiazine and small molecules, which is applied in the field of small molecule oxthiazide derivatives, and can solve problems in the preclinical research stage or clinical trial stage

Active Publication Date: 2021-03-09
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Existing research results have pointed out the direction for the design of AMPA receptor positive allosteric modulators, but most of them are in the preclinical research stage or clinical trial stage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of small molecule oxathiazide derivative and its application
  • A kind of small molecule oxathiazide derivative and its application
  • A kind of small molecule oxathiazide derivative and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Compound disclosed in this example: LT-1,8-(4-methoxyphenyl)-3,4-dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide (LT -1)

[0051]

[0052] Concrete synthetic route is as follows:

[0053]

[0054] The specific preparation method is as follows:

[0055] At 0°C, 3-bromo-2-hydroxybenzaldehyde (A01a) (5.6g, 28mmol) was dispersed in 60ml of dimethylacetamide DMA, and then aminosulfonyl chloride (10g, 86.5 mmol). The reaction system was stirred and slowly raised to room temperature until the reaction was complete. After the reaction, add water to precipitate the solid, filter and wash the filter cake with water and ethyl acetate respectively, and obtain the off-white compound as 8-bromobenzo[e][1,2,3]oxathiazine 2 with a yield of 85%. 2-dioxide (A01b).

[0056] Then A01b (2.62g, 10mmol) was dispersed in 50ml of MeOH solvent system, sodium borohydride (380mg, 10.6mmol) was added in batches at room temperature, and stirring was continued at room temperature after the add...

Embodiment 2

[0060] The compound disclosed in this example: 8-(4-methylphenyl)-3,4-dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide (LT-2).

[0061]

[0062] The synthetic route is as in Example 1, replacing "p-methoxyphenylboronic acid" with "p-tolueneboronic acid".

[0063] MS(ESI)276.1[M+H] + ; 1 H NMR (400MHz, DMSO) δ8.54(s, 1H), 7.39–7.23(m, 7H), 4.62(s, 2H), 2.36(s, 3H).

Embodiment 3

[0065] Compounds disclosed in this example: 8-(4-(tert-butyl)phenyl)-3,4-dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide (LT- 3)

[0066]

[0067] The synthetic route is as in Example 1, replacing "p-methoxyphenylboronic acid" with "p-tert-butylphenylboronic acid".

[0068] MS(ESI)318.1[M+H] + ; 1 H NMR (400MHz, DMSO) δ8.56(s, 1H), 7.51(d, J=8.4Hz, 2H), 7.43–7.34(m, 3H), 7.33–7.21(m, 2H), 4.62(s, 2H), 1.33(s, 9H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of organic synthetic medicine, and specifically relates to a small-molecule oxathiazine derivative, whose general formula is as follows: the small-molecule oxthiazine derivative can be used as a positive allosteric regulator of AMPA receptors, which proves that The compound can positively regulate the AMPA receptor, and can make the conformation of the agonist (such as endogenous neurotransmitter glutamate) more stable after binding to the receptor, thereby reducing the inactivation rate of the receptor and inhibiting the desensitization of the receptor. Enhance the function of AMPA receptors.

Description

technical field [0001] The invention relates to the technical field of innovative chemical medicines, in particular to a small molecule oxathiazine derivative and its application. Background technique [0002] AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors are an important subtype of ionotropic glutamate receptors, mainly distributed in the postsynaptic membrane of the central nervous system, Composed of four core subunits G1uR1~4, it mediates the main rapid excitatory transmission in the central nervous system, promotes neural development and outstanding plasticity, and participates in various neural activity processes. Important targets related to systemic diseases. [0003] The extracellular domain of each AMPA receptor subunit contains two domains: the amino-terminal domain (amino-terminal domain, ATD) involved in subunit assembly and the ligand-binding domain (Ligand binding domain, LBD) that provides glutamate binding. Studies have shown that t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D291/08C07D419/04C07D419/10A61P25/18A61P25/28A61P25/16A61P25/24A61K31/5415
CPCA61P25/16A61P25/18A61P25/24A61P25/28C07D291/08C07D419/04C07D419/10
Inventor 李涛漆学宇于雪莉
Owner WEST CHINA HOSPITAL SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap